Tuberculosis

Journal Title：Tuberculosis

Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis, notably on bacteriological, immunological and pathogenesis aspects of the disease. The journal publishes original research and reviews on the host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism, however discourages submissions with a meta-analytical focus (for example, articles based on searches of published articles in public electronic databases, especially where there is lack of evidence of the personal involvement of authors in the generation of such material). We do not publish Clinical Case-Studies.

Areas on which submissions are welcomed include:

-Clinical TrialsDiagnostics-

Antimicrobial resistance-

Immunology-

Leprosy-

Microbiology, including microbial physiology-

Molecular epidemiology-

Non-tuberculous Mycobacteria-

Pathogenesis-

Pathology-

Vaccine development.

This Journal does not accept case-reports.

The resurgence of interest in tuberculosis has accelerated the pace of relevant research and Tuberculosis has grown with it, as the only journal dedicated to experimental biomedical research in tuberculosis.

《結核病》是一本專業期刊，專注于結核病的基礎實驗研究，特別是該疾病的細菌學、免疫學和發病機制方面。該期刊發表關于結核病的宿主反應和免疫學以及該生物體的分子生物學、遺傳學和生理學的原創研究和評論，但不鼓勵以薈萃分析為重點的投稿（例如，基于對公共電子數據庫中已發表文章的搜索而撰寫的文章，尤其是缺乏作者個人參與此類材料生成的證據）。我們不發表臨床案例研究。

歡迎投稿的領域包括：

-臨床試驗診斷-

抗菌素耐藥性-

免疫學-

麻風病-

微生物學，包括微生物生理學-

分子流行病學-

非結核分枝桿菌-

發病機制-

病理學-

疫苗開發。

本期刊不接受病例報告。

人們對結核病興趣的復蘇加速了相關研究的步伐，Tuberculosis 也隨之發展，成為唯一致力于結核病實驗生物醫學研究的期刊。

Tuberculosis創刊于2001年，由Churchill Livingstone出版商出版，收稿方向涵蓋醫學 - 呼吸系統全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約1月 ，影響因子指數2.8，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。